Q3 2025 Holdings
Filed 2025-11-13 | 51 holdings | $395.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Maximus Inc(MMS) | COM | 577933104 | $50.9M | 557,615 | 12.9% |
| Celcuity Inc(CELC) | COM | 15102K100 | $38.9M | 786,526 | 9.8% |
| Sanofi SA(SNY) | SPONSORED ADR | 80105N105 | $26.6M | 562,703 | 6.7% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $22.7M | 577,750 | 5.8% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $20.2M | 674,840 | 5.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $18.8M | 284,787 | 4.8% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $14.9M | 177,300 | 3.8% |
| Henry Schein Inc(HSIC) | COM | 806407102 | $14.5M | 219,207 | 3.7% |
| Centene Corp del(CNC) | COM | 15135B101 | $13.8M | 387,600 | 3.5% |
| Kenvue Inc(KVUE) | COM | 49177J102 | $13.7M | 844,000 | 3.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $12.2M | 225,114 | 3.1% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $11.6M | 268,873 | 2.9% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $11.6M | 190,764 | 2.9% |
| Haemonetics Corp Mass(HAE) | COM | 405024100 | $9.7M | 198,035 | 2.4% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $8.4M | 1,498,095 | 2.1% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $8.3M | 683,819 | 2.1% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $8.0M | 1,772,601 | 2.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $7.3M | 174,841 | 1.8% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $7.2M | 514,947 | 1.8% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $5.5M | 185,265 | 1.4% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $5.3M | 413,829 | 1.4% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $5.1M | 55,723 | 1.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $5.0M | 307,181 | 1.3% |
| Teleflex Incorporated(TFX) | COM | 879369106 | $4.9M | 40,057 | 1.2% |
| Simulations Plus Inc(SLP) | COM | 829214105 | $4.8M | 320,307 | 1.2% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $4.4M | 2,075,139 | 1.1% |
| Shoulder Innovations Inc(SI) | COMMON STOCK | 82537J108 | $4.4M | 350,000 | 1.1% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $3.7M | 2,636,548 | 0.9% |
| Septerna Inc(SEPN) | COM | 81734D104 | $3.6M | 189,199 | 0.9% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $3.4M | 124,230 | 0.9% |
| Aligos Therapeutics Inc(ALGS) | COM NEW | 01626L204 | $3.3M | 335,937 | 0.8% |
| Erasca Inc(ERAS) | COM | 29479A108 | $3.0M | 1,369,748 | 0.8% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $2.7M | 478,343 | 0.7% |
| Savara Inc(SVRA) | COM | 805111101 | $2.6M | 726,851 | 0.7% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $2.6M | 829,178 | 0.7% |
| Neuroone MED Technologies Co(NMTC) | COM NEW | 64130M209 | $2.1M | 2,360,635 | 0.5% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $1.9M | 1,427,495 | 0.5% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $1.5M | 130,628 | 0.4% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $1.3M | 1,341,636 | 0.3% |
| Senseonics Holdings Inc(SENS1GBP) | COM | 81727U105 | $1.0M | 2,315,749 | 0.3% |
| Tela BIO Inc(TELA) | COM | 872381108 | $948.1K | 636,300 | 0.2% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $917.3K | 72,173 | 0.2% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $600.9K | 122,889 | 0.2% |
| Modular MED Inc(MODD) | COM NEW | 60785L207 | $549.9K | 785,824 | 0.1% |
| Nyxoah S A(NYXH) | SHS | B6S7WD106 | $233.9K | 50,839 | 0.1% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $201.3K | 163,679 | 0.1% |
| Aprea Therapeutics Inc(APRE) | COM NEW | 03836J201 | $165.5K | 112,223 | 0.0% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $75.9K | 10,100 | 0.0% |
| Nextcure Inc(NXTC) | COM NEW | 65343E207 | $64.1K | 10,940 | 0.0% |
| Rocket Pharmaceuticals Inc | *W EXP 09/02/202 | 77313F114 | $14.4K | 400,000 | 0.0% |